Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

01 Dec 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated December 1, 2022, titled ‘Zydus receives final approval from the USFDA for Topiramate Extended-Release Capsules’.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1896.00
Dr. Reddys Labs. 1376.00
Cipla 1417.00
Lupin 2021.00
Zydus Lifesciences 1190.10
View more..